The purpose of this study is to determine whether two oral formulations of Gemfibrozil Tablets are bioequivalent.

Inclusion Criteria:

• healthy men or women 18 years of age or older
• weight within +/- 20% for height and body frame
• willing to participate and sign a copy of the informed consent form

Exclusion Criteria:

• recent history of drug or alcohol addiction or abuse
• pregnant or lactating women
• history of allergic response to gemfibrozil
• use of tobacco products
• evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant
• receipt of any drugs as part of a research study within 28 days prior to study dosing